Biochemical, Immunological, and Cell Genetic Studies in Glycogenosis Type II

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1978 Mar 1

PMID 350041

Citations 29

Authors

A J Reuser

J F Koster

A Hoogeveen

H GALJAARD

Affiliations

Soon will be listed here.

Abstract

Fibroblasts from patients with the adult, juvenile, and infantile form of glycogenosis type II (Pompe disease) were cultured under standardized conditions, and the activity of acid alpha-glucosidase (E.C.3.2.1.20) towards glycogen, maltose, and 4-methylumbelliferyl-alpha-D-glucopyranoside was measured. Glycogen levels in muscle biopsies and in cultured fibroblasts from patients were determined. Residual enzyme activities varying from 7%-22% were detected in fibroblasts from patients with the adult form but not from patients with the infantile form of glycogenosis II. An inverse correlation was found between the severity of the clinical manifestation and the degree of residual enzyme activity in the fibroblasts. The kinetic and electrophoretic properties of acid alpha-glucosidase in fibroblasts from the adult patients and from control individuals were similar. Immunological studies suggested that the decrease of acid alpha-glucosidase activity is caused by a mutation that affects the production or degradation of the enzyme rather than its catalytic activity. Complementation studies were carried out by fusing fibroblasts from patients with the adult, juvenile, and infantile form of glycogenosis II, but neither conventional assays on multikaryons nor enzyme assays on single binuclear heterokaryons gave any evidence for genetic heterogeneity among these forms.

Citing Articles

Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials.

Wang H, Zhang C, Dong Z, Zhu X, Zheng X, Liu Z Viruses. 2024; 16(3).

PMID: 38543765 PMC: 10976115. DOI: 10.3390/v16030400.

The Respiratory Phenotype of Pompe Disease Mouse Models.

Fusco A, McCall A, Dhindsa J, Zheng L, Bailey A, Kahn A Int J Mol Sci. 2020; 21(6).

PMID: 32214050 PMC: 7139647. DOI: 10.3390/ijms21062256.

Micropatterned substrates with physiological stiffness promote cell maturation and Pompe disease phenotype in human induced pluripotent stem cell-derived skeletal myocytes.

Jiwlawat N, Lynch E, Napiwocki B, Stempien A, Ashton R, Kamp T Biotechnol Bioeng. 2019; 116(9):2377-2392.

PMID: 31131875 PMC: 6699746. DOI: 10.1002/bit.27075.

The impact of Pompe disease on smooth muscle: a review.

McCall A, Salemi J, Bhanap P, Strickland L, Elmallah M J Smooth Muscle Res. 2019; 54(0):100-118.

PMID: 30787211 PMC: 6380904. DOI: 10.1540/jsmr.54.100.

Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Raval K, Tao R, White B, de Lange W, Koonce C, Yu J J Biol Chem. 2014; 290(5):3121-36.

PMID: 25488666 PMC: 4317045. DOI: 10.1074/jbc.M114.628628.

References

Koster J, Slee R . Some properties of human liver acid alpha-glucosidase. Biochim Biophys Acta. 1977; 482(1):89-97. DOI: 10.1016/0005-2744(77)90357-6. View

Jeffrey P, Brown D, Brown B . Studies of lysosomal alpha-glucosidase. II. Kinetics of action of the rat liver enzyme. Biochemistry. 1970; 9(6):1416-22. DOI: 10.1021/bi00808a016. View

GALJAARD H, Mekes M, Josselin de Jong JE D, Niermeijer M . A method for rapid prenatal diagnosis of glycogenosis II (Pompe's disease). Clin Chim Acta. 1973; 49(3):361-75. DOI: 10.1016/0009-8981(73)90234-9. View

Engel A . Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain. 1970; 93(3):599-616. DOI: 10.1093/brain/93.3.599. View

de Barsy T, Jacquemin P, Devos P, HERS H . Rodent and human acid -glucosidase. Purification, properties and inhibition by antibodies. Investigation in type II glycogenosis. Eur J Biochem. 1972; 31(1):156-65. DOI: 10.1111/j.1432-1033.1972.tb02514.x. View

Koster J, Slee R, Hulsmann W . The use of leucocytes as an aid in the diagnosis of a variant of glycogen storage disease type II (Pompe's disease). Eur J Clin Invest. 1972; 2(6):467-71. DOI: 10.1111/j.1365-2362.1972.tb00678.x. View

Engel A, Gomez M, Seybold M, LAMBERT E . The spectrum and diagnosis of acid maltase deficiency. Neurology. 1973; 23(1):95-106. DOI: 10.1212/wnl.23.1.95. View

Angelini C, Engel A . Subcellular distribution of acid and neutral alpha-glucosidases in normal, acid maltase deficient, and myophosphorylase deficient human skeletal muscle. Arch Biochem Biophys. 1973; 156(1):350-5. DOI: 10.1016/0003-9861(73)90374-3. View

Thomas G, Taylor H, Miller C, Axelman J, MIGEON B . Genetic complementation after fusion of Tay-Sachs and Sandhoff cells. Nature. 1974; 250(467):580-2. DOI: 10.1038/250580a0. View

10.

Angelini C, Engel A . Comparative study of acid maltase deficiency. Biochemical differences between infantile, childhood, and adult types. Arch Neurol. 1972; 26(4):344-9. DOI: 10.1001/archneur.1972.00490100074007. View

11.

HUDGSON P, Fulthorpe J . The pathology of type II skeletal muscle glycogenosis. A light and electron-microscopic study. J Pathol. 1975; 116(3):139-47. DOI: 10.1002/path.1711160303. View

12.

GALJAARD H, Hoogeveen A, Reuser A, Keijzer W, Westerveld A, BOOTSMA D . Tay-Sachs and Sandhoff's disease: intergenic complementation after somatic cell hybridization. Exp Cell Res. 1974; 87(2):444-8. DOI: 10.1016/0014-4827(74)90515-1. View

13.

GALJAARD H, Hoogeveen A, Reuser A, Ho M, Robinson D . Genetic heterogeneity in GM1-gangliosidosis. Nature. 1975; 257(5521):60-2. DOI: 10.1038/257060a0. View

14.

Palmer T . The maltase, glucoamylase and transglucosylase activities of acid -glucosidase from rabbit muscle. Biochem J. 1971; 124(4):713-24. PMC: 1177248. DOI: 10.1042/bj1240713. View

15.

Rosenfeld E . Alpha-glucosidases (gamma-amylases) in human and animal organisms. Pathol Biol (Paris). 1975; 23(1):71-84. View

16.

Reuser A, JONGKIND J, GALJAARD H . Methods for analysis of acid alpha-1,4-glucosidase activity in single hybrid cells. J Histochem Cytochem. 1976; 24(4):578-86. DOI: 10.1177/24.4.1063791. View

17.

Smith J, ZELLWEGER H, Afifi A . Muscular form of glycogenosis, type II (Pompe). Neurology. 1967; 17(6):537-49. DOI: 10.1212/wnl.17.6.537. View

18.

Huijing F . A rapid enzymic method for glycogen estimation in very small tissue samples. Clin Chim Acta. 1970; 30(3):567-72. DOI: 10.1016/0009-8981(70)90246-9. View

19.

Mehler M, DiMauro S . Residual acid maltase activity in late-onset acid maltase deficiency. Neurology. 1977; 27(2):178-84. DOI: 10.1212/wnl.27.2.178. View